National Institute of Neurological Disorders and Stroke, 46847 [2014-18849]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 154 / Monday, August 11, 2014 / Notices
Committee must notify the Contact Person
listed on this notice by 5:00 p.m. ET on
Friday, September 12, 2014, with their
request to present oral comments at the
meeting. Interested individuals and
representatives of organizations must submit
a written/electronic copy of the oral
statement/comments including a brief
description of the organization represented
by 5:00 p.m. ET on Wednesday, September
17, 2014.
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: August 1, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–18857 Filed 8–8–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of an Interagency Pain
Research Coordinating Committee
(IPRCC) meeting.
The meeting will feature invited
speakers and discussions of committee
business items including strategic
planning for Federal pain research and
the National Pain Strategy.
The meeting will be open to the
public and accessible by live webcast
and conference call.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: September 24, 2014.
Time: 8:30 a.m. to 5:00 p.m. *Eastern
Time*—Approximate end time.
Agenda: The meeting will feature invited
speakers and discussions of Committee
business items including the National Pain
Strategy and long term strategic planning for
Federal pain research.
Place: National Institutes of Health,
Building 31, C Wing, 6th Floor, Conference
Room 10, 31 Center Drive, Bethesda, MD
20892.
Call in Teleconference Line (Listen Only):
Dial: 888–945–5891, Participant Passcode:
1242293.
Cost: The meeting is free and open to the
public.
Webcast Live: https://videocast.nih.gov/.
Deadlines: Notification of intent to present
oral comments: Friday, September 12, 2014,
by 5:00 p.m. ET.
Submission of written/electronic statement
for oral comments: Wednesday, September
17, 2014, by 5:00 p.m. ET.
Submission of written comments: Friday,
September 19, 2014, by 5:00 p.m. ET.
Access: Medical Center Metro (Red Line),
Visitor Information: https://www.nih.gov/
about/visitor/index.htm.
Contact Person: Linda L. Porter, Ph.D.,
Pain Policy Advisor, Office of Pain Policy,
Officer of the Director, National Institute of
Neurological Disorders and Stroke, NIH, 31
Center Drive, Room 8A03, Bethesda, MD
20892, Phone: (301) 451–4460, Email:
Linda.Porter@nih.gov.
Please Note: Any member of the public
interested in presenting oral comments to the
VerDate Mar<15>2010
17:35 Aug 08, 2014
Jkt 232001
Statements submitted will become a
part of the public record. Only one
representative of an organization will be
allowed to present oral comments on
behalf of that organization, and
presentations will be limited to three to
five minutes per speaker, depending on
number of speakers to be accommodated
within the allotted time. Speakers will
be assigned a time to speak in the order
of the date and time when their request
to speak is received, along with the
required submission of the written/
electronic statement by the specified
deadline. If special accommodations are
needed, please email the Contact Person
listed above.
In addition, any interested person
may submit written comments to the
IPRCC prior to the meeting by sending
the comments to the Contact Person
listed on this notice by 5:00 p.m. ET,
Friday, September 19, 2014. The
comments should include the name
and, when applicable, the business or
professional affiliation of the interested
person. All written comments received
by the deadlines for both oral and
written public comments will be
provided to the IPRCC for their
consideration and will become part of
the public record.
The meeting will be open to the
public through a conference call phone
number and webcast live on the
Internet. Members of the public who
participate using the conference call
phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with
the conference call or webcast, please
call Operator Service on (301) 496–4517
for conference call issues and the NIH
IT Service Desk at (301) 496–4357, toll
free (866) 319–4357, for webcast issues.
Individuals who participate in person
or by using these electronic services and
who need special assistance, such as
captioning of the conference call or
other reasonable accommodations,
should submit a request to the Contact
Person listed on this notice at least
seven days prior to the meeting.
As a part of security procedures,
attendees should be prepared to present
a photo ID during the security process
to get on the NIH campus. For a full
description, please see: https://
www.nih.gov/about/visitorsecurity.htm.
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
46847
Information about the IPRCC is
available on the Web site: https://
iprcc.nih.gov/.
Dated: August 4, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–18849 Filed 8–8–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Announcement of Requirements and
Registration for ‘‘Follow that Cell’’
Challenge
Authority: 15 U.S.C. 3719.
Through the ‘‘Follow that
Cell’’ Challenge (the ‘‘Challenge’’), the
Single Cell Analysis Program (SCAP)—
https://commonfund.nih.gov/Singlecell/
index, a component of the National
Institutes of Health Common Fund—
https://commonfund.nih.gov/about, is
searching for novel methods for
analyzing dynamic states of individual
cells that can serve as the basis for
predicting alterations in cell behavior
and function over time. The goal of the
Challenge is to develop new tools and
methods that allow time-dependent
measurements at the single-cell level in
a complex tissue environment in order
to assess functional changes, provide
information on the health status of a
given cell, and help guide diagnosis and
therapeutic treatments related to human
disease states. Technological
breakthroughs in this arena could allow
researchers and physicians to identify
rare cells in a mixed population, such
as individual cells that can transform
and become cancerous, cells that are
latently infected with a pathogenic
virus, or cells that develop resistance to
drugs over time.
The NIH Common Fund currently
supports SCAP grants, the majority of
which are associated with academic
institutions. This Challenge, structured
in two phases, will strengthen and
complement the existing SCAP grant
portfolio by reaching out to a more
diverse population of innovators and
solvers, including not only those who
are from academic institutions but also
those who are from research and
development communities in the
private sector and those who are outside
biomedical disciplines. The NIH
believes this Challenge will stimulate
investment from both public and private
sectors in single-cell analysis research
and product development, which, in
SUMMARY:
E:\FR\FM\11AUN1.SGM
11AUN1
]]>Agencies
[Federal Register Volume 79, Number 154 (Monday, August 11, 2014)]
[Notices]
[Page 46847]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-18849]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of an Interagency Pain
Research Coordinating Committee (IPRCC) meeting.
The meeting will feature invited speakers and discussions of
committee business items including strategic planning for Federal pain
research and the National Pain Strategy.
The meeting will be open to the public and accessible by live
webcast and conference call.
Name of Committee: Interagency Pain Research Coordinating
Committee.
Type of meeting: Open Meeting.
Date: September 24, 2014.
Time: 8:30 a.m. to 5:00 p.m. *Eastern Time*--Approximate end
time.
Agenda: The meeting will feature invited speakers and
discussions of Committee business items including the National Pain
Strategy and long term strategic planning for Federal pain research.
Place: National Institutes of Health, Building 31, C Wing, 6th
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
Call in Teleconference Line (Listen Only): Dial: 888-945-5891,
Participant Passcode: 1242293.
Cost: The meeting is free and open to the public.
Webcast Live: https://videocast.nih.gov/.
Deadlines: Notification of intent to present oral comments:
Friday, September 12, 2014, by 5:00 p.m. ET.
Submission of written/electronic statement for oral comments:
Wednesday, September 17, 2014, by 5:00 p.m. ET.
Submission of written comments: Friday, September 19, 2014, by
5:00 p.m. ET.
Access: Medical Center Metro (Red Line), Visitor Information:
https://www.nih.gov/about/visitor/index.htm.
Contact Person: Linda L. Porter, Ph.D., Pain Policy Advisor,
Office of Pain Policy, Officer of the Director, National Institute
of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room
8A03, Bethesda, MD 20892, Phone: (301) 451-4460, Email:
Linda.Porter@nih.gov.
Please Note: Any member of the public interested in presenting
oral comments to the Committee must notify the Contact Person listed
on this notice by 5:00 p.m. ET on Friday, September 12, 2014, with
their request to present oral comments at the meeting. Interested
individuals and representatives of organizations must submit a
written/electronic copy of the oral statement/comments including a
brief description of the organization represented by 5:00 p.m. ET on
Wednesday, September 17, 2014.
Statements submitted will become a part of the public record. Only
one representative of an organization will be allowed to present oral
comments on behalf of that organization, and presentations will be
limited to three to five minutes per speaker, depending on number of
speakers to be accommodated within the allotted time. Speakers will be
assigned a time to speak in the order of the date and time when their
request to speak is received, along with the required submission of the
written/electronic statement by the specified deadline. If special
accommodations are needed, please email the Contact Person listed
above.
In addition, any interested person may submit written comments to
the IPRCC prior to the meeting by sending the comments to the Contact
Person listed on this notice by 5:00 p.m. ET, Friday, September 19,
2014. The comments should include the name and, when applicable, the
business or professional affiliation of the interested person. All
written comments received by the deadlines for both oral and written
public comments will be provided to the IPRCC for their consideration
and will become part of the public record.
The meeting will be open to the public through a conference call
phone number and webcast live on the Internet. Members of the public
who participate using the conference call phone number will be able to
listen to the meeting but will not be heard. If you experience any
technical problems with the conference call or webcast, please call
Operator Service on (301) 496-4517 for conference call issues and the
NIH IT Service Desk at (301) 496-4357, toll free (866) 319-4357, for
webcast issues.
Individuals who participate in person or by using these electronic
services and who need special assistance, such as captioning of the
conference call or other reasonable accommodations, should submit a
request to the Contact Person listed on this notice at least seven days
prior to the meeting.
As a part of security procedures, attendees should be prepared to
present a photo ID during the security process to get on the NIH
campus. For a full description, please see: https://www.nih.gov/about/visitorsecurity.htm.
Information about the IPRCC is available on the Web site: https://iprcc.nih.gov/.
Dated: August 4, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-18849 Filed 8-8-14; 8:45 am]
BILLING CODE 4140-01-P
